Open AccessLong-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus
Author(s) -
Carmela Benson,
Bruno Émond,
Hela Romdhani,
Patrick Lefèbvre,
Aurélie CôtéSergent,
Azadeh Shohoudi,
Neeta Tandon,
Wing Chow,
Keith Dunn
Publication year - 2019
Publication title -
journal of managed care and specialty pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.126
H-Index - 63
eISSN - 2376-1032
pISSN - 2376-0540
DOI - 10.18553/jmcp.2019.19174
Subject(s) - medicine , medicaid , pharmacy , regimen , protease inhibitor (pharmacology) , reverse transcriptase inhibitor , health care , pediatrics , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load , family medicine , economic growth , economics
New guidelines for the treatment of human immunodeficiency virus (HIV) suggest that morbidity and mortality could be reduced if antiretroviral therapy (ART) was initiated immediately after diagnosis, regardless of CD4 cell count.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom